ověřování biochemických a farmakologických vlastností ... · 1st faculty of medicine,...

29
Neuroimaging I: 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI)

Upload: lydat

Post on 19-Apr-2019

220 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

Neuroimaging I:

1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI)

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI)

Page 2: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Shoghi-Jadid et al., 2002

Page 3: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

NeuroimagingObtaining evidence from the brain

• Lesion studies – stroke, trauma (PET, SPECT, CT, MRI)

• Cerebral blood flow (PET, SPECT, CT, MRI)

• Neurotransmitter Imaging (PET, SPECT, fMRI)

• Neuro-Receptor Imaging (PET, SPECT)

• Dissease specific Imaging (Multimodal)

Page 4: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Neuroimaging“The Big 10”

• Infarction

• Hemorrhage

• Infection

• Tumor

• Trauma

• Dementia

• MS

• Epilepsy

• Cranial neuropathy

• Orbits / Ophtho dx

Page 5: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

NeuroimagingImaging Approaches

Structural Functional

X-ray

MRI

CT/CAT

fMRI

PET

SPECT

EEG ECG

PET/CT

SPECT/CT

PET/MRI

Multimodal

Page 6: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Anatomical Brain Imaging

Page 7: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Anatomical Brain ImagingCT

Hyperdense MCA Insular Ribbon Lentiform Nucleus

CT Signs in Early MCA Ischemia

Page 8: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Anatomical Brain ImagingStructural MRI

• Essential in clinical care

• Radiologists perform qualitative “lightbox”

reads

• Most psychiatric and neurological

disorders are invisible to reading

radiologists

Page 9: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Anatomical Brain ImagingT1 MRI

designed (timing of radio pulses and data readout) to produce contrastbetween gray matter, white matter, and CSF

Spatial resolution: ca. 1 mm3, Acquisition time for whole head is 5-10 minutes

Page 10: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Anatomical Brain ImagingT1 MRI – Image Zoom

• Can follow GM cortex fairly well

– Can measure thickness of

cortex and try to quantify vs

age and/or disease and/or

genes

• Bright spots and lines: arterial

inflow artifact

– Leads to idea of MRA =

Magnetic Resonance

Angiography = acquire

images to make arteries

stand out even more

• Higher spatial resolution is

possible

– At the cost of scan time

Page 11: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Anatomical Brain ImagingT2 MRI

Often better than T1-weighting in detecting tumors and infarcts

(usually radiologists look at both types of scans)

T1 weighted T2 weighted

Page 12: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Anatomical Brain ImagingT2* MRI

Designed to make venous blood (with lots of deoxy-hemoglobin)

darker than normal tissue = venography

Output image minIP ± 1 slice minIP ± 2 slices

Page 13: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Anatomical Brain ImagingContrast enhanced MRI

T2-weighted post-contrast T1-weighted

Tumor Seizure Patient

Gd-enhanced

T1-weighted

Gd-enhanced

T2*-weighted

Page 14: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Functional Brain Imaging

Page 15: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Functional Brain ImagingEnergy Metabolism 18F-FDG

Normal Multiple Infarct

Dementia

Huntington's

Normal Alzheimer's Pick's

Page 16: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Functional Brain ImagingEnergy Metabolism 18F-FDG

Page 17: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Functional Brain ImagingNeurotransmitter 18F-FDOPA

Page 18: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Functional Brain ImagingAmino Acid Transport

Imaging of 49-y-old woman who had been previously treated for glioblastoma

multiforme with tumor resection and conventional radiotherapy at dose of 60 Gy. (A)

T1-weighted MR image with contrast medium, obtained 13 mo after initial surgery,

showing contrast-enhanced lesion in left frontal lobe. (B) 11C-MET PET image

showing obvious accumulation of tracer corresponding to abnormality on MR image.

L/Nmeanwas 1.70. Recurrent tumor was pathologically confirmed by second surgery.

Page 19: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Zubieta et al. - Journal of Cerebral Blood Flow & Metabolism (1998) 18, 619–631

Functional Brain ImagingAmino Acid Transport – Glycine transporter 1

[11C]GSK931145 distribution in a healthy volunteer

Pig Primate Human

Page 20: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Neuroreceptor Imaging

Page 21: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Selected Receptor Tracers

Page 22: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Neuro-Receptor ImagingDAT – dopamine transporter

Page 23: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

11C-DTBZ K1 and 18F-FDG images at 3 brain levels for one representative subject from each group. Robert A. Koeppe et al. J Nucl Med 2005;46:936-944

Neuro-Receptor ImagingVMAT2 – vesicular monoamine transporter type 2

Page 24: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Neuro-Receptor Imaging5-HT2A receptor

Horizontal PET images showing the uptake of [11C]NMSP in the frontal cortex at the level of the basal ganglia at baseline, and after the administration of 2 mg, 10 mg and 100 mg oral doses of an inverse agonist (ACP-103)

Page 25: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

microPET and autoradiography studies of PRG/PRP imaging of gene expression in the same mouse. PRG is D2 receptor, and PRPis FESP. (Left) MicroPET image of a single 1.5-mm-thick longitudinal section of living control mouse negative for D2 receptor (D2

−)PRG, showing no significant retention of PRP in liver (dashed lines). In animal carrying dopamine receptor reporter gene (D2

+),there is retention of FESP PET reporter probe in liver reflecting gene expression. Images were taken 50 min after injection of FESPand 2 days after virus administration. (Right) After microPET imaging, animals were killed, sectioned, and imaged withautoradiography

Michael E. Phelps PNAS 2000;97:9226-9233

Neuro-Receptor ImagingD2 receptor – 11c-Fluorethylspiperone (FESP)

Page 26: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Neuro-Receptor ImagingGABAA-benzodiazepine receptor

Magnetic resonance imaging (MRI) and delayed-activity positron emission tomography (PET)

with [11C]flumazenil and single photon emission computed tomography (SPECT) with [123I]iomazenil

images of one subject at different anatomic levels

Millet et al.; Journal of Cerebral Blood Flow & Metabolism (2000) 20, 1587–1603

Page 27: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Neuro-Receptor ImagingOpioid Receptor

PET scan of a six month old rhesus macaque using a [C-11]diprenorphine tracer,

specific for opioid receptors.

Page 28: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

Neuro-Receptor ImagingMuscarinic Receptor

Quantification of muscarinic cholinergic receptors with [11C]N-methyl-4-piperidyl benzylate ([11C]NMPB) -

distribution parameters and activity

Zubieta et al. - Journal of Cerebral Blood Flow & Metabolism (1998) 18, 619–631

Page 29: Ověřování biochemických a farmakologických vlastností ... · 1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI) s.eigner@seznam.cz

1st Faculty of Medicine, Charles University in Prague

Center for Advanced Preclinical Imaging (CAPI) [email protected]

THANK YOU FOR YOUR ATTENTION